Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses

Vaccine

Volumn 28, Issue 37, 2010, Pages 6052-6057

  Almeida, Coral Ann M ^a   Roberts, Steven G ^a   Laird, Rebecca ^a   McKinnon, Elizabeth ^a   Ahmad, Imran ^a   Keane, Niamh M ^a   Chopra, Abha ^a   Kadie, Carl ^b   Heckerman, David ^b   Mallal, Simon ^a,c   John, Mina ^a,c  

^a MURDOCH UNIVERSITY   (Australia)

^b MICROSOFT RESEARCH   (United States)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

CD8 T cells; HIV 1; HLA alleles

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; EPITOPE; HLA A ANTIGEN; PEPTIDE;

ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; CONSENSUS SEQUENCE; GENETIC POLYMORPHISM; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY;

CD8-POSITIVE T-LYMPHOCYTES; CONSENSUS SEQUENCE; EPITOPES, T-LYMPHOCYTE; FEMALE; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HUMANS; INTERFERON-GAMMA; MALE; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PEPTIDES; POLYMORPHISM, GENETIC;

EID: 77955519298     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.091     Document Type: Article

References (24)

1. Brumme Z.L., John M., Carlson J.M., Brumme C.J., Chan D., Brockman M.A., et al. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 2009, 4(8):e6687.
2. Altfeld M., Addo M.M., Shankarappa R., Lee P.K., Allen T.M., Yu X.G., et al. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol 2003, 77(13):7330-7340.
3. Goulder P.J., Watkins D.I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev 2008, 8(8):619-630.
4. Zimbwa P., Milicic A., Frater J., Scriba T.J., Willis A., Goulder P.J.R., et al. Precise identification of a human immunodeficiency virus type 1 antigen processing mutant. J Virol 2007, 81(4):2031-2038.
5. Novitsky V., Flores-Villanueva P.O., Chigwedere P., Gaolekwe S., Bussman H., Sebetso G., et al. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. Hum Immunol 2001, 62(2):146-156.
6. Moore C.B., John M., James I.R., Christiansen F.T., Witt C.S., Mallal S.A. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002, 296(5572):1439-1443.
7. Brumme Z.L., Brumme C.J., Heckerman D., Korber B.T., Daniels M., Carlson J., et al. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog 2007, 3(8):e121.
8. Carlson J.M., Brumme Z.L. HIV evolution in response to HLA-restricted CTL selection pressures: a population-based perspective. Microbes Infect 2008, 10(5):455-461.
9. Rousseau C.M., Daniels M.G., Carlson J.M., Kadie C., Crawford H., Prendergast A., et al. HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load. J Virol 2008, 82(13):6434-6446.
10. Malhotra U., Li F., Nolin J., Allison M., Zhao H., Mullins J.I., et al. Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection. J Virol 2007, 81(10):5225-5237.
11. Frahm N., Kaufmann D.E., Yusim K., Muldoon M., Kesmir C., Linde C.H., et al. Increased sequence diversity coverage improves detection of HIV-specific T cell responses. J Immunol 2007, 179(10):6638-6650.
12. Li F., Malhotra U., Gilbert P.B., Hawkins N.R., Duerr A.C., McElrath J.M., et al. Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation. Vaccine 2006, 24(47-48):6893-6904.
13. Frahm N., Nickle D.C., Linde C.H., Cohen D.E., Zuñiga R., Lucchetti A., et al. Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity. AIDS 2008, 22(4):447-456.
14. Mallal S.A. The Western Australian HIV Cohort Study, Perth, Australia. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 17(Suppl. 1):S23-S27.
15. John M., Heckerman D., James I., Park L.P., Carlson J.M., Chopra A., et al. Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA Class I molecules with common supertype motifs. J Immunol 2010, 184(8):4368-4377.
16. Heckerman D., Kadie C., Listgarten J. Leveraging information across HLA alleles/supertypes improves epitope prediction. J Comput Biol 2007, 14(6):736-746.
17. Korber B.T.M., Brander C., Haynes B.F., Koup R., Moore J.P., Walker B.D., et al. HIV molecular immunology 2006/2007 2006/2007, Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, United States of America.
18. Almeida C.A., Roberts S.G., Laird R., McKinnon E., Ahmed I., Pfafferott K., et al. Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses. J Immunol Methods 2009, 344(1):1-5.
19. Karlsson A.C., Martin J.N., Younger S.R., Bredt B.M., Epling L., Ronquillo R., et al. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods 2003, 283(1-2):141-153.
20. Sidney J., Peters B., Frahm N., Brander C., Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol 2008, 9:1.
21. Frahm N., Korber B.T., Adams C.M., Szinger J.J., Draenert R., Addo M.M., et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 2004, 78(5):2187-2200.
22. Kaufmann D.E., Bailey P.M., Sidney J., Wagner B., Norris P.J., Johnston M.N., et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol 2004, 78(9):4463-4477.
23. Turk G., Gherardi M.M., Laufer N., Saracco M., Luzzi R., Cox J.H. Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants. J Virol 2008, 82(6):2853-2866.
24. Precopio M.L., Butterfield T.R., Casazza J.P., Little S.J., Richman D.D., Koup R.A., et al. Optimizing peptide matrices for identifying T-cell antigens. Cytometry A 2008, 73(11):1071-1078.